DOUTOR NICHIRES Holdings Co., Ltd. (TYO:3087)
Japan · Delayed Price · Currency is JPY 3,090.00
+25.00 (0.82%)
Jul 24, 2026, 3:30 PM JST
DOUTOR NICHIRES Holdings Income Statement
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
| 162,360 | 159,147 | 148,822 | 140,625 | 126,864 | 109,363 | |
Revenue Growth (YoY) | 7.36% | 6.94% | 5.83% | 10.85% | 16.00% | 13.75% |
Cost of Revenue | 66,953 | 65,455 | 59,201 | 56,436 | 52,094 | 45,048 |
Gross Profit | 95,407 | 93,692 | 89,621 | 84,189 | 74,770 | 64,315 |
Selling, General & Admin | 84,257 | 83,540 | 80,023 | 76,866 | 71,800 | 66,098 |
Operating Expenses | 84,257 | 83,540 | 80,023 | 76,866 | 71,800 | 66,098 |
Operating Income | 11,150 | 10,152 | 9,598 | 7,323 | 2,970 | -1,783 |
Interest Expense | -27 | -26 | -27 | -17 | -15 | -13 |
Interest & Investment Income | 90 | 90 | 46 | 34 | 29 | 30 |
Earnings From Equity Investments | -11 | -10 | -51 | -19 | -7 | -21 |
Currency Exchange Gain (Loss) | 292 | 296 | -52 | 269 | 376 | 162 |
Other Non Operating Income (Expenses) | 113 | 112 | 99 | 109 | 111 | 145 |
EBT Excluding Unusual Items | 11,607 | 10,614 | 9,613 | 7,699 | 3,464 | -1,480 |
Gain (Loss) on Sale of Investments | -146 | -146 | - | 45 | - | - |
Gain (Loss) on Sale of Assets | 11 | 8 | 9 | 27 | 6 | 1 |
Asset Writedown | -824 | -817 | -598 | -920 | -1,302 | -3,160 |
Other Unusual Items | 315 | 269 | 277 | 596 | 1,855 | 8,066 |
Pretax Income | 10,963 | 9,928 | 9,301 | 7,447 | 4,023 | 3,427 |
Income Tax Expense | 3,051 | 2,661 | 2,385 | 1,911 | 562 | 2,168 |
Earnings From Continuing Operations | 7,912 | 7,267 | 6,916 | 5,536 | 3,461 | 1,259 |
Minority Interest in Earnings | -28 | -33 | -36 | -45 | -32 | -38 |
Net Income | 7,884 | 7,234 | 6,880 | 5,491 | 3,429 | 1,221 |
Net Income to Common | 7,884 | 7,234 | 6,880 | 5,491 | 3,429 | 1,221 |
Net Income Growth | 19.91% | 5.15% | 25.30% | 60.13% | 180.83% | - |
Shares Outstanding (Basic) | 42 | 42 | 44 | 44 | 44 | 44 |
Shares Outstanding (Diluted) | 42 | 42 | 44 | 44 | 44 | 44 |
Shares Change (YoY) | -1.06% | -3.33% | -0.31% | -0.56% | 0.01% | 0.03% |
EPS (Basic) | 187.53 | 170.71 | 156.95 | 124.88 | 77.55 | 27.61 |
EPS (Diluted) | 187.53 | 170.71 | 156.95 | 124.88 | 77.55 | 27.61 |
EPS Growth | 24.70% | 8.77% | 25.69% | 61.03% | 180.82% | - |
Free Cash Flow | - | 1,926 | 6,491 | 7,327 | 142 | 10,429 |
Free Cash Flow Per Share | - | 45.45 | 148.08 | 166.63 | 3.21 | 235.87 |
Dividend Per Share | - | - | 50.000 | 40.000 | 30.000 | 26.000 |
Dividend Growth | - | - | 25.00% | 33.33% | 15.38% | 8.33% |
Gross Margin | 58.76% | 58.87% | 60.22% | 59.87% | 58.94% | 58.81% |
Operating Margin | 6.87% | 6.38% | 6.45% | 5.21% | 2.34% | -1.63% |
Profit Margin | 4.86% | 4.54% | 4.62% | 3.91% | 2.70% | 1.12% |
Free Cash Flow Margin | - | 1.21% | 4.36% | 5.21% | 0.11% | 9.54% |
EBITDA | 15,830 | 14,817 | 14,202 | 11,580 | 6,883 | 2,401 |
EBITDA Margin | 9.75% | 9.31% | 9.54% | 8.24% | 5.42% | 2.20% |
D&A For EBITDA | 4,680 | 4,665 | 4,604 | 4,257 | 3,913 | 4,184 |
EBIT | 11,150 | 10,152 | 9,598 | 7,323 | 2,970 | -1,783 |
EBIT Margin | 6.87% | 6.38% | 6.45% | 5.21% | 2.34% | -1.63% |
Effective Tax Rate | 27.83% | 26.80% | 25.64% | 25.66% | 13.97% | 63.26% |